Junko Moriuchi
Tokai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Junko Moriuchi.
Autoimmunity | 1994
Terumi Horiki; Hidetoshi Inoko; Junko Moriuchi; Yukinobu Ichikawa; Shigeru Arimori
HLA class II alleles in the DQA1, DQB1, DRB1, and DPB1 genes were investigated in Japanese patients with myasthenia gravis (MG) by digestion of polymerase chain reaction amplified DNAs with allele specific restriction endonucleases (PCR-RFLP). A significantly higher frequency of DQB1*03, which includes *0301, *0302, *0303 and determines the serological DQ3 specificity, was observed in female patients less than 30 years in age at onset of disease compared with healthy controls (90.5 vs. 53.2%). This study also confirms the high incidence of DPB1*0201 in early-onset female patients compared to the controls (85.7 vs. 40.3%). Moreover, 81.0% of the early onset female patients were found to carry both DQB1*03 and DPB1*0201, compared to 17.7% of the controls. Since DQB1*03 and DPB1*0201 are not in linkage disequilibrium, both these alleles are supposed to be synergistically involved in disease development in early-onset female MG. In contrast, no obvious association of HLA-DQA1, DQB1, DRB1 and DPB1 alleles with either late-onset patients or patients with thymoma was observed. Clearly, the genetic background of Japanese females with early onset MG is different from that of other patients with MG.
Human Heredity | 1993
Merica Pavlovic; Peter Kay; Junko Moriuchi; Philip F. Jacobsen; John M. Papadimitriou
Genetic polymorphism of the epidermal growth factor (EGF) receptor gene following Taq I digestion was compared between samples of genomic DNA from glioma-derived cell lines and Caucasoid and Japanese subjects. The same three allelic forms of the EGF receptor gene, marked by variant fragments of approximately 12.8, 11.6 and 10.8 kb in size were common to both ethnic groups and the 12.8- and 11.6-kb fragments were found in the glioma-derived cell line DNA. A further variant fragment of approximately 13.8 kb in size has been shown to be thus far restricted to the Japanese. These data suggest that most allelic forms of the EGF receptor gene recognized by Taq I restriction fragment length polymorphism have a long evolutionary history and probably do not predispose to development of malignant glioma.
Lupus | 1992
Yukinobu Ichikawa; Kazunaga Takamatsu; Hiroaki Shimizu; Mitsuaki Uchiyama; Junko Moriuchi; Masatoshi Takaya; Nobumasa Kobayashi; Tsutomu Kawada; Shigeru Arimori
Anticardiolipin antibodies (aCL) were recently discovered to recognize a complex consisting of phospholipids and apolipoprotein H (apo H). In this study, we determined the serum apo H levels in 36 systemic lupus erythematosus (SLE) patients with or without antiphospholipid antibodies (aPL), including aCL and lupus anticoagulants, to clarify the possible effects of aPL on apo H levels in vivo. The apo H levels were low in SLE patients as compared with 22 healthy controls. However, no associations were found between apo H levels and circulating aPL or clinical features of the antiphospholipid antibody syndrome. A secondary hyperlipidemic state, which probably related to lupus nephritis (proteinuria) and/or prednisolone treatment, increased apo H levels in SLE patients.
Immunogenetics | 1992
Peter Kay; Junko Moriuchi; P.J. Ma; Emma Saueracker
The use of DNA probes specific for constant regions of immunoglobulin heavy and light chain genes as well as T-cell receptor (Tcr) subunit genes is now firmly established in the routine diagnosis and classification of non-Hodgkins lymphoma (Arnold et al. 1983; Waldmann et al. 1985; Daus et al. 1989). As detailed by Cossman and co-workers (1988), there are many factors to be considered in interpretation of data derived from molecular biological techniques used in lymphoma classification studies. For example, there is considerable allelism of Tcr and immunoglobulin genes reflected by restriction fragment length polymorphisms (RFLPs) of genomic DNA representing the germline configuration. Consequently, RFLPs marking rare allelic forms of immunoglobulin or Tcr subunit genes may be wrongly interpreted as reflecting monoclonality of a population of cells of lymphoid origin. In Caucasoids, the most common pattern of fragments hybridizing with an immunoglobulin lambda light chain constant region (IGLC2) probe following digestion of genomic DNA with Eco RI comprises fragments with sizes of approximately 8, 14, and 16 kilobases (kb). The 14 and 16 kb fragments are invariant, whereas the 8 kb fragment represents the most frequent allelic form of the IGLC2 genes (Taub et al. 1983; Ghanem et al. 1988). Less frequent allelic forms of the IGLC2 genes are marked by fragments with sizes of approximately 13, 18, or 23 kb. The 13 and 18 kb and probably the 23 kb fragments are due to insertion of 1, 2, or 3 repeats of a 5.2 kb fragment respectively within the 8 kb allele (Taub et al. 1983). Since rare allelic forms of the IGLC2 genes may be misinterpreted as markers of monoclonality in the absence of ap-
Japanese Journal of Rheumatology | 1997
Terumi Horiki; Junko Moriuchi; Ryouko Kouzuma; Munetaka Haida; Satoru Watanabe; Yoji Katsuoka; Yukinobu Ichikawa
A 29-year-old female with systemic lupus erythematosus who developed accerelated hypertension, motor paralytic bladder and various other neurological abnormalities is described. Cystometry demonstrated flaccid atonic neuropathic bladder. Elevated protein level and albuminocytologic dissociation were recognized in her cerebral spinal fluid. Magnetic resonance imaging study detected high signal intensities in themedulla oblongata andcauda equina. Her clinical symptoms and laboratory abnormalities were resolved after two courses of methyl-prednisolone pulse therapy. Possible roles of antiphospholipid antibodies were considered in the pathogenesis of her neurologic abnormalities.
Clinical and Experimental Rheumatology | 1991
Masatoshi Takaya; Yukinobu Ichikawa; Kobayashi N; Kawada T; Hiroaki Shimizu; Uchiyama M; Junko Moriuchi; Watanabe K; Shigeru Arimori
Arthritis & Rheumatism | 1996
Terumi Horiki; Junko Moriuchi; Masatoshi Takaya; Mitsuaki Uchiyama; Yuichi Hoshina; Kenichi Inada; Hidetoshi Inoko; Kmiyoshi Tsuji; Yukinobu Ichikawa
Clinical and Experimental Rheumatology | 1995
Yukinobu Ichikawa; Arimori K; Miyoko Yoshida; Horiki T; Hoshina Y; Morita K; Uchiyama M; Hiroaki Shimizu; Junko Moriuchi; Masatoshi Takaya
Arthritis & Rheumatism | 1986
Junko Moriuchi; Yukinobu Ichikawa; Masatoshi Takaya; Hiroaki Shimizu; Mitsuaki Uchiyama; Kaoru Sato; Kimiyoshi Tsuji; Shigeru Arimori
Clinical and Experimental Rheumatology | 1989
Junko Moriuchi; Yukinobu Ichikawa; Takaya M; Shimizu H; Tokunaga M; Eguchi T; Izumi M; Ohta W; Katsuoka Y; Nakajima I